Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Gene SureSeq MyPanel NGS Custom Cancer Panels

Oxford Gene Technology has launched its SureSeq myPanel NGS custom cancer panels. The panels are hybridization-based and use a custom set of probes to deliver complete and uniform coverage of genes of interest to users without the need for fill-in Sanger sequencing, the company said. They also include a comprehensive library of gene content which covers key cancer types including, myeloid, chronic lymphocytic leukemia, ovarian, and breast. 

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.